One Comprehensive Universal Radiotherapy for Everyone (1-CURE)
- Response deadline
- May 23, 2026 Closed
- Date posted
- Apr 29, 2026
- Source
- Open notice
Description
Amendment 3: Revised Appendix F: Administrative & National Policy Requirements Document, Section 3, Paragraph 1, to state that the Biographical Common Form, the Current and Pending (other) Support Common Form, and the Collaborators and Other Affiliations attachments may be provided during the negotiation phase after proposal selection. Amendment 2: Added Appendices J & K under the Attachments section. Amendment 1: Added Appendices A - I separately under the Attachments section. The Advanced Research Projects Agency for Health (ARPA-H) is posting this Innovative Solutions Opening (ISO) in support of the One Comprehensive Universal Radiotherapy for Everyone (1-CURE) Program. ARPA-H anticipates that multiple Other Transaction (OT) Agreements will result from this announcement. Interested parties are invited to review the attached 1-CURE_ISO_ARPA-H-SOL-26-147 and its Appendices A - C. Additionally, proposers are encouraged to review the separate Special Notice, ARPA-H-SN-26-152, for information regarding the 1-CURE Proposers� Day. Special Notice, ARPA-H-SN-26-152, is an independent announcement and is not attached to this ISO announcement. All questions submitted to the ISO will be compiled and addressed. All answers will be posted to the 1-CURE Frequently Asked Questions (FAQ) page. Potential proposers are encouraged to monitor the FAQs page regularly for the latest information and updates: https://arpa-h.gov/explore-funding/programs/1-cure/faqs
Classifications
Documents
No documents posted for this opportunity.
Similar contracts
- Quantitative Analysis of Longitudinal MR ImagesMarylandDue Nov 9, 2026
- ARPA-H Emerging Health Innovators (EHI) InitiativeDistrict of ColumbiaDue Feb 10, 2027
- Q--Amplicon Sequencing ServicesDue Nov 5, 2026
- Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
- Development/Production - Kidney GEC-Specific AAV VectorMODue Nov 4, 2026
- Pre-Clinical Models of Infectious DiseasesDue Dec 7, 2026